Geometric Mean Titer | Factor-increase in Geometric Mean Titer (95% CI) | |||
---|---|---|---|---|
N | Before Immunization, % (95% CI) | After Immunization, % (95% CI) | ||
Control | 91 | 12.4 (9.7–15.7) | 250.8 (196.3–320.3) | 20.3 (15.6–26.4) |
JARD | 237 | 11.4 (9.7–13.3) | 147.2 (119.7–181.1)* | 12.9 (10.7–15.7)* |
JSLE | 99 | 10.9 (8.5–13.9) | 91.1 (66.0–125.8)* | 8.4 (6.3–11.2)* |
JIA | 93 | 10.8 (8.4–13.8) | 217.2 (159–296.7) | 20.2 (14.8–27.5) |
JDM | 18 | 15.3 (8.9–26.3) | 201.6 (95.4–425.8) | 13.2 (7.2–24.1) |
JScl | 11 | 12.1 (6.0–24.2) | 181.5 (70.2–469.4) | 15.0 (6.3–35.9) |
Primary vasculitis | 16 | 14.1 (6.8–29.2) | 182.2 (68.1–487.4) | 12.9 (5.9–28.2) |
↵* p < 0.05. JARD: juvenile autoimmune rheumatic diseases; JSLE: juvenile systemic lupus erythematosus; JIA: juvenile idiopathic arthritis; JDM: juvenile dermatomyositis; JScl: juvenile scleroderma.